Stopping lamivudine therapy after biochemical breakthrough may be a feasible option in selected HBeAg-positive patients
2004 ◽
Vol 41
(3)
◽
pp. 454-461
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):